Get help finding a supplier  

Supplier Type of Service Brief Description
An (*) indicates a supplier offering a discount for COVID-19 related services and/or products.
ACGT, Inc.* Omics Services DNA sequencing, NGS, and molecular diagnostics services available and are prioritizing SARS-CoV-2 (COVID-19)-related projects
Advaita Bioinformatics* Omics Services The iPathwayGuide platform can be used to analyze mRNA, protein, methylation, and many other types of data from SARS-CoV-2 (COVID-19)-related studies
Amaryllis Nucleics* Omics Services RNAseq library and strand-specific RNA-seq kits and are prioritizing SARS-CoV-2 (COVID-19)-related projects
BGI Genomics Omics Services Provides a COVID-19 total solution including one-stop nucleic acid extraction and automation as well as a 2019-nCoV RT-PCR detection kit.
Dalton Bioanalytics* Omics Services Provides multi-omic research services for SARS-CoV-2 (COVID-19) patient plasma samples.
Dante Labs* Omics Services Provides whole genome sequencing services of individuals with SARS-CoV-2 (COVID-19) to researchers, as well as, Whole Genome Sequencing for research projects on SARS-CoV-2 (COVID-19).
DHMRI Services, Inc.* Omics Services Providing genomic and metabolomic research services and instrumentation for SARS-CoV-2 (COVID-19) research projects
Fulgent Genetics Omics Services Provides RT-PCR and Next Genration Sequencing Virus Teating for SARS-CoV-2 (COVID-19) testing
Lipotype GmbH* Omics Services Certified to analyze SARS-CoV-2 (COVID-19) samples and prioritizing projects to confirmed COVID-19 patient samples for lipid analysis based on Lipotype Shotgun Lipidomics Technology.
Loop Genomics* Omics Services Small Genome Assembly and LoopSeq Genome Sequencing to include: library preparation & single molecule counting long-read sequencing with 1/25k error rate for SARS-CoV-2 (COVID-19) research projects
McGill University and Genome Quebec Innovation Centre* Omics Services Grant awarded to SARS-CoV-2 (COVID-19) researchers. The funded projects would have access to our Core platform genomics services.
Novogene Corporation* Omics Services Prioritizing SARS-CoV-2 (COVID-19) research projects for Genomics and NGS services.
Proteome Sciences plc Omics Services Using LC-MS2 Mass Spectrometry (MS) methods with TMT labelled tryptic peptides, we can analyze how viral infection changes cellular protein synthesis and abundance, revealing cellular pathways strongly modulated upon SARS-CoV-2 (COVID-19) infection.
Quick Biology Inc.* Omics Services Different SARS-CoV-2 (COVID-19) NGS projects ranging from WGS, RNA-seq and amplicon seq.
OnRamp Bioinformatics* Omics Services ROSALIND platform for real-time, global collaboration and analysis on important genomic datasets
c-LEcta – DENARASE Omics Services Enzyme used for DNA removal in viral and protein based vaccine processes. Source: Serratia marcescens, GMP compliance and available in bulk quantities
AUM BioTech, LLC Omics Services AUM BioTech is a biotechnology company that offers RNA silencing solutions for gene screening, target validation, and loss-of-function studies. AUM's next generation FANA Antisense Oligonucleotide (FANA ASO) Technology provides robust alternatives to CRISPR, siRNA and shRNA approaches. FANA ASOs can be used to silence or regulate RNA modalities such as – mRNA, microRNA and long non-coding RNA. FANA ASOs can be used for screening, identification, and discovery of genetic targets. Our approach also allows high throughput and fast functional genomics studies and thus potentially reducing the time for development of therapeutics for viral infections. It provides potent viral RNA knockdown by using FANA technology and is designed to degrade or sterically block viral RNA. FANA ASO platform offers high sequence specificity, high stability and allows potent self-delivery into cellular and animals models without the need of transfection reagents or formulations. Some key features of FANA Antisense Oligonucleotides include: • Self-Deliverable (Does Not Require Transfection Reagents) in difficult to transfect cells. • Single Step Protocol • In Vitro and In Vivo Applications • No Off-Target Effects AUM's FANA ASO Technology is used globally by scientists and researchers working on basic, transitional and preclinical research.